Recently I published a post on Ashish Bharadwaj’s article Patent Injunction and the Public Interest in India, 40 EIPR 55-58 (2018), discussing the author’s reservations about the Delhi High Court’s ruling last year in Bayer Intellectual Property GmbH v Ajanta Pharma Ltd that a “public interest” factor …
